Research output: Contribution to journal › Article › peer-review
Characteristic Profiles of Biologically Active Substances of Blood Plasma Samples from Patients with Tuberculosis Obtained by HPLC. / Solov’eva, S. A. ; Bessonova, E. A. ; Kartsova, L. A. .
In: Journal of Analytical Chemistry, Vol. 74, No. 6, 74, 2019, p. 570-573.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Characteristic Profiles of Biologically Active Substances of Blood Plasma Samples from Patients with Tuberculosis Obtained by HPLC
AU - Solov’eva, S. A.
AU - Bessonova, E. A.
AU - Kartsova, L. A.
N1 - Solov’eva, S.A., Bessonova, E.A. & Kartsova, L.A. Characteristic Profiles of Biologically Active Substances of Blood Plasma Samples from Patients with Tuberculosis Obtained by HPLC. J Anal Chem 74, 570–573 (2019). https://doi.org/10.1134/S1061934819040142
PY - 2019
Y1 - 2019
N2 - Toxic metabolites (N-acetylisoniazid, pyrazinoic acid, and desacetylrifampicin) of first-line anti-tuberculosis drugs (ethambutol, pyrazinamide, rifampicin, and isoniazid) are identified by liquid chromatography–mass spectrometry, which is important in selecting the required dosages of these drugs for the maximum therapeutic effects and the reduction of side effects. Characteristic chromatographic profiles of blood plasma samples from donors with pulmonary tuberculosis (“pathology”) and a clinically healthy group (“norm”) are obtained and processed by principal component analysis and the k-nearest neighbor method. A perspective of this approach for obtaining of additional diagnostic criteria for pulmonary tuberculosis is shown.
AB - Toxic metabolites (N-acetylisoniazid, pyrazinoic acid, and desacetylrifampicin) of first-line anti-tuberculosis drugs (ethambutol, pyrazinamide, rifampicin, and isoniazid) are identified by liquid chromatography–mass spectrometry, which is important in selecting the required dosages of these drugs for the maximum therapeutic effects and the reduction of side effects. Characteristic chromatographic profiles of blood plasma samples from donors with pulmonary tuberculosis (“pathology”) and a clinically healthy group (“norm”) are obtained and processed by principal component analysis and the k-nearest neighbor method. A perspective of this approach for obtaining of additional diagnostic criteria for pulmonary tuberculosis is shown.
KW - ВЭЖХ, биологически активные вещества, туберкулез, сыворотка крови
KW - first-line anti-tuberculosis drugs
KW - metabolites
KW - HPLC–mass spectrometry
KW - characteristic profiles of biologically active compounds
KW - chemometrics
UR - https://link.springer.com/article/10.1134/S1061934819040142
U2 - DOI 10.1134/S1061934819040142
DO - DOI 10.1134/S1061934819040142
M3 - Article
VL - 74
SP - 570
EP - 573
JO - Journal of Analytical Chemistry
JF - Journal of Analytical Chemistry
SN - 1061-9348
IS - 6
M1 - 74
ER -
ID: 52420630